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ABSTRACT 12 
Sewer pipelines, although primarily designed for sewage transport, can also be considered as bioreactors. In-13 
sewer processes may lead to significant variations of chemical loadings from source release points to the 14 
treatment plant influent. In this study, we assessed in-sewer utilization of growth substrates (primary metabolic 15 
processes) and transformation of illicit drug biomarkers (secondary metabolic processes) by suspended biomass. 16 
Sixteen drug biomarkers were targeted, including mephedrone, methadone, cocaine, heroin, codeine and 17 
tetrahydrocannabinol (THC) and their major human metabolites. Batch experiments were performed under 18 
aerobic and anaerobic conditions using raw wastewater, and abiotic biomarker transformation and partitioning to 19 
suspended solids and reactor wall were separately investigated under both redox conditions. A process model 20 
was identified by combining and extending Wastewater Aerobic/anaerobic Transformations in Sewers model 21 
(WATS) and Activated Sludge Model for Xenobiotics (ASM-X). Kinetic and stoichiometric model parameters 22 
were estimated using experimental data via the Bayesian optimization method DREAM(ZS). Results suggest that 23 
biomarker transformation significantly differs from aerobic to anaerobic conditions, and abiotic conversion is the 24 
dominant mechanism for many of the selected substances. Notably, explicit description of biomass growth 25 
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during batch experiments was crucial to avoid significant overestimation (up to 385%) of aerobic 26 
biotransformation rate constants. Predictions of in-sewer transformation provided here can reduce the 27 
uncertainty in the estimation of drug consumption as part of wastewater-based epidemiological studies. 28 
   29 
INTRODUCTION 30 
Over the past decade, wastewater-based epidemiology (WBE) has emerged as a promising approach to provide 31 
policy makers with improved knowledge of consumption and abuse of illicit drugs, based on the analysis of 32 
excreted parent drugs and/or their human metabolites in untreated sewage.
1,2
 In this emerging field, temporal and 33 
spatial patterns of drug use have been identified and characterized in selected urban sewer catchments;
3–6
 34 
allowing, more recently, for the undertaking of international comparative studies.
7,8
 Therefore, WBE has the 35 
potential to complement the conventional surveillance data on drug abuse.
9
 In order to ensure reliable and robust 36 
epidemiological engineering tools (mathematical and experimental methods that can be used to predict the 37 
substance usage rate in an urban catchment), ongoing research is currently addressing various sources of 38 
uncertainties and deficiencies,
4,10
 the most common being associated with the performance of the analytical 39 
methods used (e.g. matrix effect, analytical variability, and validation).
4,11
 The notion of in-sewer stability has 40 
also been introduced to describe the transformation of drug biomarkers between a theoretical discharge point and 41 
the sampling point at the influent of wastewater treatment plant (WWTP).
12–16
 However, very few attempts have 42 
been made to refine calculations of drug consumption by accounting for in-sewer transformation of drug 43 
biomarkers.
3
  44 
Accounting for in-sewer fate of drug biomarkers in back-calculation schemes requires a mathematical 45 
description of physical and biochemical processes. Considering drug biomarkers as organic micropollutants 46 
(such as pharmaceuticals, personal care products and their metabolites), models developed for these chemicals 47 
could be relevant, such as multimedia fugacity and activity-based models
17–19
 or concentration-based models.
13,20
 48 
More specifically, the Activated Sludge Model for Xenobiotic trace chemicals (ASM-X)
13
 was proposed to 49 
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describe transformation and sorption processes for pharmaceuticals in wastewater treatment systems, and has 50 
been further applied for predicting the fate of cocaine biomarkers in wastewater.
3
  51 
The application of water quality models to sewer systems is based on the concept that the sewer network is 52 
considered as a bioreactor where biochemical transformations occur.
21
 Transformation kinetics, and thus the 53 
wastewater composition in sewers, can be impacted by the design features and the operation regimes (e.g. 54 
gravity-driven or pressurized pipe) implemented in sewer systems.
22
 The microbial community and the 55 
underlying biochemical processes in sewers require a different characterization than for WWTPs in terms of 56 
availability of growth substrates, terminal electron acceptors, and fraction of active biomass. For instance, 57 
high-substrate-to-microorganism ratios are often expected for raw wastewater in sewer, while lower 58 
ratios occur in activated sludge reactors of full-scale WWTPs.23 Based on these concepts, the Wastewater 59 
Aerobic/anaerobic Transformations in Sewers (WATS) modeling framework was introduced to describe 60 
microbially-mediated aerobic transformation of organic carbon
24,25
 and biochemical processes related to the 61 
nitrogen and sulfur cycle.
23,26,27
 Furthermore, high substrate-to-microorganism ratios in untreated sewage require 62 
accounting for significant microbial growth when describing biotransformation of drug biomarkers during 63 
stability tests, thus influencing the estimation of transformation kinetics.  64 
To date, comprehensive studies assessing the influence of different factors (e.g. redox conditions, abiotic 65 
processes) on the in-sewer transformation of drug biomarkers are still limited.
3,28
 Moreover, while the majority 66 
of studies have focused on the stability of individual biomarkers, drug metabolites present in spiking solutions 67 
during targeted experiments can potentially transform to each other (an observations that can be made only with 68 
adequate chemical labeling). These transformation pathways should be included in fate models, and the common 69 
term stability appears to simplify this challenge.  70 
The main objectives of this study were: (i) to characterize abiotic and microbially-mediated transformation and 71 
sorption of illicit drugs in raw wastewater under aerobic and anaerobic conditions, by means of targeted batch 72 
experiments; (ii) to identify and calibrate a mathematical model for combined description of in-sewer microbial 73 
growth kinetics (based on WATS) and drug biomarker sorption and transformation (based on ASM-X); (iii) to 74 
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identify the simplest transformation pathways and structures for ASM-X process model extensions for selected 75 
illicit drug biomarkers; and (iv) to evaluate the optimal model complexity for the reliable prediction of 76 
biomarker fate in bulk raw wastewater. 77 
 78 
MODELING FRAMEWORK 79 
In-sewer processes for the utilization of primary organic substrate (measured as chemical oxygen demand—80 
COD), electron acceptors (oxygen, sulfate) and the fate of drug biomarkers are described separately. The 81 
structure of process models, rate equations, stoichiometric coefficients and definitions of model state-variables 82 
and model parameters are presented in Table 1. Since experiments in this study were carried out strictly under 83 
either aerobic or anaerobic conditions, the processes relevant for each distinct redox conditions are formulated 84 
separately for WATS model. In Table 1, ASM-X process rates under aerobic and anaerobic conditions are 85 
considered identical as previously suggested.
3
 86 
 87 
Primary metabolic processes (WATS) 88 
In-sewer transformation of organic matter and growth of heterotrophic (XHw) and sulfate reducing bacteria (SRB, 89 
XSRB) were described according to literature.
23,24,29–32
 Oxygen (SO) and sulfate (SSO4) were considered as terminal 90 
electron acceptors under aerobic and anaerobic conditions, thus neglecting processes under denitrifying 91 
conditions. Process rates only describe transformation and partitioning of chemicals, and the simulation model 92 
does not account for in-sewer transport processes. Evaporation of methanol (SMe) was additionally considered 93 
and described using a first-order equation (Supporting Information Section S1.3). All process rates include an 94 
Arrhenius-based correction to account for the effect of temperature. Further details of WATS model can be 95 
found in SI Section S1. 96 
 97 
Secondary metabolic processes (ASM-X) 98 
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A model for the fate of drug biomarkers in wastewater was developed based on the ASM-X modeling 99 
framework.
3
 Biotransformation of drug biomarkers as non-growth substrates was expressed as a second-order 100 
rate equation proportional to (i) the aqueous concentration of the drug biomarker, CLI; and (ii) the concentration 101 
of active biomass, XHw  and/or XSRB. Due to their high diversity and their ability to oxidize a variety of organic 102 
compounds,
33–35
 SRB species were also considered capable of degrading drug biomarker under anaerobic 103 
conditions. Hence, the impact of the utilization of organic matter fractions and the associated significant 104 
microbial growth on biomarker biotransformation was considered by combining WATS and ASM-X 105 
(WATS⎼ASM-X). The extent of biotransformation kinetics is described by the biotransformation rate constant 106 
kbio (L gCOD
-1
 d
-1
).  107 
ASM-X was further extended to account for additional fate processes, namely (i) first-order abiotic 108 
transformation, described by the abiotic transformation rate constant kabio (d
-1
), and (ii) sorption and desorption 109 
of drug biomarkers onto reactor wall, with definition of the partition coefficient (Kdw) between reactor wall and 110 
liquid. The latter processes were considered to reflect observed drug biomarker concentrations in blank 111 
experiments (typically a decreasing trend, with pronounced initial drop indicative of partitioning to reactor wall) 112 
(Figure 1 and SI Figure S11). Sorption to and desorption from particulate matter were regarded as two opposite 113 
equilibrium processes.
20
 Drug biomarkers in aqueous phase were considered capable of partitioning onto 114 
suspended solids (XSS, gTSS L
-1
) including hydrolysable organic matter (XS1+XS2 as TSS) and active biomass 115 
(XHw+XSRB as TSS). The solid-liquid partition coefficient, Kd (L g
-1
), was normalized to the total suspended solids 116 
(TSS) concentration, and a fixed conversion factor (fSS, gTSS gCOD
-1
) was used to convert COD-based state-117 
variables to TSS using experimental data (not shown). CSL and CSW denote the concentration of drug biomarkers 118 
in the solid phase and on reactor wall, respectively. Due to varying area of the reactor wall in contact with the 119 
liquid phase during batch experiments (caused by sample withdrawal), a variable wet-surface area-to-volume 120 
ratio (σw) was defined (SI Section S5.4).  121 
Transformation pathways of drug biomarker were assessed individually considering the possible transformation 122 
of biomarkers and simultaneous formation from other biomarkers present in the spiking mixture. An additional 123 
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state-variable (CCJ) was thus considered, denoting the concentration of other biomarkers transforming to CLI. 124 
Identified transformation pathways and complete Gujer matrices defined for each group of drug biomarkers are 125 
presented in SI Section S6. Abiotic transformation and biotransformation pathways for each chemical in water 126 
and wastewater, respectively, were primarily identified based on relevant literature
3,36–38
 and confirmed by 127 
statistical analysis via post-processing after model calibration. Feasibility of biodegradation pathways were also 128 
attested using EAWAG-BBD Pathway Prediction System
39
 (SI Figure S27). 129 
 130 
MATERIALS AND METHODS  131 
Selection of trace organic biomarkers 132 
We selected 16 illicit drug biomarkers based on their relevance and frequency of occurrence as demonstrated 133 
through a recent wastewater monitoring campaign in European cities
8
 and EMCDDA reports.
40
 Biomarkers were 134 
subdivided into five groups: (i) mephedrone (MEPH); (ii) methadone (METD) and its metabolite 2-ethylidene-135 
1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP); (iii) cocaine (COC) and its metabolites benzoylecgonine (BE), 136 
ecgonine methyl ester (EME), and cocaethylene (CE); (iv) heroin (HER) and its metabolites 6-137 
monoacetylmorphine (6MAM), morphine (MOR), and morphine-3-β-D-glucuronide (MORG); codeine (COE) 138 
and its metabolite norcodeine (NCOE); (v) tetrahydrocannabinol (THC) and its metabolites 11-hydroxy-∆9-THC 139 
(THCOH), and 11-nor-9-carboxy-∆9-THC (THCCOOH). Analytical standards and their isotopically labeled 140 
internal standard (ILIS) analogues were purchased from Sigma Aldrich (Brøndby, Denmark) at concentrations of 141 
0.1 mg mL
-1
 and 1 mg mL
-1
, respectively. Corresponding stock solutions were prepared by dilution in methanol 142 
(MeOH) at final concentration of 10 and 42 μg mL-1. Physicochemical properties of the compounds are 143 
presented in SI Table S3.  144 
 145 
Laboratory-scale batch experiments 146 
Sorption and transformation of selected drug biomarkers were assessed using batch experiments in jacketed 147 
reactors. An external recirculating bath was used to control wastewater temperature at 14⎼15 °C throughout the 148 
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experiments. A diffuser was placed at the bottom of each reactor and sparging of dry compressed atmospheric 149 
air or pure nitrogen was used to create aerobic or anaerobic conditions, respectively. Reactors were further 150 
equipped with a mixing impeller from the top.  151 
Three different sets of batch experiments were conducted: (i) biotransformation experiments with raw 152 
wastewater (BT); (ii) sorption experiments with diluted primary sludge with addition of sodium azide (SO); and 153 
(iii) abiotic experiments with mineral water (AB). Two procedures of BT experiments were carried out. In the 154 
first procedure (BT-P1), analytical standards were spiked with an initial concentration at 10 µg L
-1
 (higher than 155 
background concentrations) in the reactors and considered as the main target chemicals. Isotopically labeled 156 
internal standards (ILIS) were used to evaluate the analytical procedure and spiked into collected samples prior 157 
to sample treatment. In the second procedure (BT-P2), ILIS were spiked at 2 µg L
-1
 in the reactors and targeted, 158 
and thus allowing for the determination of direct transformation of illicit drugs without any interference from 159 
background concentrations.
15
 For other experiments, (i.e. SO and AB) only the first procedure (P1) was 160 
employed. For all experiments, grab samples of raw wastewater and primary sludge were collected from 161 
Mølleåværket WWTP (Lundtofte, Denmark; SI Section S2). The solution containing the drug biomarkers was 162 
added in the batch reactors and the first sample (t = 0) was collected after two minutes to allow for mixing of 163 
biomarkers in the medium (each sample volume=260 mL). TSS, volatile suspended solids (VSS), temperature, 164 
and pH were monitored during experiments and are reported as average value ± standard deviation. An overview 165 
of all experiments is presented in SI Table S4. 166 
 167 
Biotransformation Experiments (BT) 168 
For BT-P1 experiments (aerobic: 0.32±0.04 gTSS L
-1
, pH=8.8±0.1, T=14.3±0.1 °C; anaerobic: 0.32±0.05 gTSS 169 
L
-1
, pH=8.3±0.2, T=15.3±0.2 °C), raw wastewater was collected in June 2015, three hours prior to start-up of 170 
batch experiments. For BT-P2 experiments (aerobic: final 1.28±0.14 gTSS L
-1
, pH=8.7±0.1, T=15±0.4 °C; 171 
anaerobic: 1.29±0.07 gTSS L
-1
, pH=8.1±0.3, T=15.5±0.1 °C) raw wastewater was collected in October 2014 and 172 
kept overnight at 4 °C for decantation. Settled wastewater solids were subsequently diluted (1:2) with newly 173 
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sampled raw sewage and used for experiments. Spiking solution for BT-P2 experiments contained ILIS only for 174 
MEPH, METD, EDDP, COC, BE, EME, CE (not for anaerobic experiment) and 6MAM.  Aerobic and anaerobic 175 
experiments were conducted in parallel over 48 h, with an initial wastewater volume of 7 L. Over the course of 176 
experiments, nine and twelve samples were collected for BT-P1 and BT-P2, respectively. Due to deficiency in 177 
nitrogen sparging system, oxygen was transferred to anaerobic BT-P1 reactor (2–3.8 mgO2 L
-1
) over the last 4 h 178 
of the experiment. Hence, all data at t=48 h for anaerobic BT-P1 was neglected for model calibration purposes.   179 
Respirometry tests were used to monitor microbial respiration and characterize different COD fractions in the 180 
wastewater inoculum according to their biodegradability.
41–45
 Briefly, aliquots of the wastewater used as 181 
inoculum for BT-P1 (t=0) were collected and used for biological oxygen demand (BOD) monitoring (Oxitop®, 182 
WTW, Germany) over 48 h (T=20 °C), based on which oxygen uptake rates (OUR) were calculated. We 183 
assumed that the biomass activity in the BOD bottles would be approximately identical with the biomass activity 184 
in BT-P1 aerobic experiment as both systems were operated with the same wastewater medium without 185 
limitation of oxygen. To account for temperature differences, Arrhenius-based correction factors of bacterial 186 
growth were used. Moreover, the COD fractionation was assumed to be applicable for BT-P1 anaerobic 187 
experiment at t=0. A detailed description of the respirometry method is presented in SI Section S1.2.  188 
 189 
Sorption Experiments (SO) 190 
Primary sludge samples were first mixed with tap water to remove already sorbed chemicals for a period of 12 h 191 
(wash-off step). The amount of sorbed chemicals that remained in the solid phase was assumed to be negligible 192 
compared to the spiked amount (initial concentration at 10 μg L-1). Following centrifugation (20 min, 4700 rpm) 193 
and dilution of the extract with wastewater effluent, sodium azide (0.05% v/v) was added to the mixture to 194 
inhibit microbial degradation. SO1 experiment with initial volume of 7 L (0.32±0.02 gTSS L
-1
,
 
pH=8.4±0.1, 195 
T=15.2±0.1 °C) and SO2 with initial volume of 4 L (0.41±0.03 gTSS L
-1
, pH=7.8±0.1, T=15±0.1 °C) were 196 
performed at different pH levels representative of conditions in corresponding aerobic and anaerobic BT 197 
experiments. 198 
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 199 
Abiotic Experiments (AB) 200 
AB experiments were performed: (i) to assess abiotic process kinetics independent of microbial transformation 201 
and estimate abiotic degradation rate constants kabio; (ii) to quantify partitioning of drug biomarkers to reactor 202 
wall; and (iii) correcting the estimation of Kd by accounting for mass loss e.g. by hydrolysis and sorption to 203 
reactor wall. Therefore, in parallel with BT-P1 experiments, two abiotic control experiments were conducted 204 
under aerobic (AB-BT aerobic, pH=8.8±0.02, T=14.9±0.4 °C) and anaerobic (AB-BT anaerobic, pH=8.7±0.6, 205 
T=15.2±0.1 °C) conditions. An initial 7-L working volume of mineral water spiked with biomarkers was used. 206 
Two additional control experiments, AB-SO1 at pH=8.7±0.04, T=14.2±0.1 °C, and AB-SO2 at pH=7.9±0.1, 207 
T=14.8±0.2 °C, were also carried out with mineral water to mimic the conditions of SO1and SO2 experiments 208 
respectively in terms of pH, redox conditions, presence of sodium azide and reactor volume.  209 
 210 
Sample preparation and analysis 211 
Chemical analysis was carried out using colorimetric methods for total COD and soluble COD (HACH Lange, 212 
Germany) and sulfate (Merck, Germany) according to international standards.
46
 Samples for dissolved chemical 213 
analyses were filtered (0.45 µm cellulose acetate filters, Sartorius, Germany) and stored at -20 °C until analysis. 214 
Concentrations of selected volatile fatty acids (formate, acetate and propionate) and lactate were also quantified 215 
in filtered samples. After thawing, samples were injected through HPLC Fast Acid Analysis Column (100 mm x 216 
7.8 mm, BIO-RAD, Denmark). For quantification, a calibration curve with six points was prepared ranging from 217 
0.5 to 100 mg L
-1
. TSS was measured using gravimetric analysis following filtration (0.6 µm glass fiber filter, 218 
Advantec, USA). 219 
For drug biomarkers determination (BT-P1 experiments), samples were spiked with ILIS at 360 ng L
-1
 220 
immediately after sampling and stored at -20 °C until analysis. Following thawing at room temperature, samples 221 
were filtered using a 0.6 µm glass fiber filter (GA-55, Advantec, Germany) before further treatment. In SO 222 
experiments, samples were filtered immediately after collection to avoid additional contact time between 223 
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aqueous phase and suspended solids during storage and thawing. The difference between the nominal spiked 224 
concentration and the measured initial (t=0) concentration can be due to the chemical loss through sample 225 
filtration. However, for samples with internal standards and ILIS, the loss of internal standards can be corrected 226 
by a loss of ILIS. All samples were extracted by solid phase extraction (150 mg, 6 cc, Oasis HLB, Waters, 227 
Denmark) and analysed with liquid chromatography coupled to high resolution mass spectrometry (HPLC-LTQ-228 
Orbitrap).
47
 Further details on the analytical method for drug biomarkers determination can be found in SI 229 
Section S3. Experimental parameters used for drug biomarkers determination are presented in SI Table S5.  230 
 231 
Model parameter estimation 232 
A number of WATS and ASM-X model parameters (underlined parameters in Table 1) were estimated via direct 233 
calculation from experimental results or parameter estimation using a global optimization algorithm (for details 234 
see SI section S7).   235 
 236 
Direct estimation of parameters 237 
OUR results derived from respirometry tests with the wastewater inoculum were used for: (i) estimation of 238 
initial concentrations of different COD fractions in BT-P1 experiments; (ii) calculation of maximum specific 239 
growth rate (µH), maintenance rate (qm) and heterotrophic yield (YHw), the latter by analyzing the OUR response 240 
to propionate spiking. A six-step methodology for COD fractionation and parameter calculation is presented in 241 
detail in SI Section S1.2. Partition coefficients Kdw and Kd were estimated using AB-BT and SO experimental 242 
data, respectively, and by assuming that sorption onto wall and suspended solids reached equilibrium within 15 243 
min and 4 h, respectively. These assumptions were based on previous considerations
3
 and observation of 244 
measured data. Kdw was calculated as: 245 
weqLI
eqSW
dw
C
C
K
σ,
,=           (1) 246 
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in which CLI is the aqueous concentration at equilibrium (t=15 min) and CSW (g L
-1
) is equal to the difference 247 
CLI,t=15min – CLI,t=0  in AB-SO experiments. A similar equation was derived for Kd at equilibrium: 248 
SSlosseqLI
losseqSL
d
XCC
CC
K
)( ,
,
+
−
=         (2) 249 
Closs (equal to the difference CLI,t=4h – CLI,t=0 in AB-SO1 and AB-SO2 experiments) was deducted from the sorbed 250 
concentration (CSL,eq) and added to the aqueous concentration (CLI,eq) at equilibrium to account for any mass loss 251 
not attributable to sorption onto suspended solids (i.e. by hydrolysis or sorption to reactor wall). Additional 252 
information on the calculation of partition coefficients is presented in SI Section S5.3.  253 
 254 
Parameter estimation via optimization  255 
The rapid hydrolysis rate (kh1) in aerobic WATS was estimated by comparing simulation results with 256 
corresponding OUR data, obtained from respirometry experiments. Transformation rate constants (kabio and kbio) 257 
in ASM-X and WATS⎼ASM-X combined model were estimated using AB-BT and BT-P1 experimental data. 258 
Parameter estimation was carried out using the Bayesian optimization method Differential Evolution Adaptive 259 
Metropolis (DREAM(ZS))
48
. The objective function was defined as the normalized sum of squared error (SSE): 260 
2
1 1 min,,max,,
,,∑∑
= =








−
−
=
n
i
m
j jiji
jiji
OO
PO
SSE       (3) 261 
where n is the number of measurements series, m the number of the data points in each series,  denotes 262 
measured data and  the model predictions, ,	 
 and ,	  the maximum and minimum of measurements, 263 
respectively. Details on the calibration methodology and identifiability of model parameters are presented in SI 264 
Section S.7.  265 
 266 
Model simulation and evaluation 267 
Model simulation and calibration was performed using Matlab R2014a (MathWorks, US). WATS was initialized 268 
using the measured and estimated concentrations of different COD fractions and SO4. ASM-X was initialized 269 
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using measurements for CLI, estimations of CSL from Eq. 2 based on measured CLI data prior to spiking (SI 270 
Figure S8) and assuming negligible initial Csw.  271 
In order to assess the importance of accounting for microbial growth, the estimation of kbio was carried out using 272 
two model complexity levels: (i) the full WATS⎼ASM-X framework (Table 1), thus accounting for the 273 
dynamics of active biomass concentration (unit of kbio: L gCOD
-1 
d
-1
); (ii) simplified modeling framework of 274 
ASM-X with fixed initial biomass (unit of kbio: L gCOD
-1 
d
-1
), i.e. no microbial growth. An additional modeling 275 
scenario was considered for the estimation of TSS-normalized k
*
bio values (unit of k
*
bio: L gTSS
-1 
d
-1
) that could 276 
be compared with findings from previous studies
3,14,49
 and used to assess the relative contribution of abiotic and 277 
biotic processes to the overall transformation of a drug biomarker.  278 
The accuracy of predictions by the WATS⎼ASM-X model was further assessed by comparing the simulation 279 
outputs with the BT-P2 dataset. We note that, for BT-P2 experiments, since no additional internal standards 280 
(rather than the ILIS listed in Table S3) were spiked to correct for any mass loss during sample treatment or the 281 
effect of sample matrix
47
, the dataset from BT-P2 was only used for model evaluation (as an independent 282 
dataset) and not for parameter estimation.  BT-P2 experiments differed from BT-P1 in terms of raw sewage 283 
composition and TSS concentration (3-fold difference) and of the use of non-deuterated or deuterated internal 284 
standards (ILIS).  285 
 286 
RESULTS AND DISCUSSION 287 
Wastewater characterization  288 
Based on the analysis of respirometric data, the total COD (977 gCOD m
-3
) in raw wastewater used for the BT-289 
P1 experiment was characterized as 1.8% XHw, 12.9% SA, 6% SF, 15.2% XS1, 43.6% XS2, and 20.5% SMe (SI Table 290 
S2). XSRB was assumed to be 4 gCOD m
-3 
and, only for the aerobic experiment, considered as a fraction of XS2.
32
  291 
The comparison with reference respirometric results revealed that the presence of MeOH (0.024% v/v) in the 292 
biomarker spiking solution did not significantly affect the respiration process, thus indicating limited utilization 293 
of MeOH as growth substrate over the 2-d experiment (SI Section S1.3). Methanol utilization by SRB species 294 
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under anaerobic conditions was considered negligible as only few SRB strains can utilize MeOH.
34
  Wastewater 295 
sample used for BT-P2 experiments assumed to have the same characterization as BT-P1 sample by adjusting 296 
COD fractions to measured total COD (5440 gCOD m
-3
)
 
and methanol (1800 gCOD m
-3
). 297 
 298 
Primary substrates 299 
Using the WATS model, concentration dynamics of different COD fractions (substrate and biomass) during BT-300 
P1 batch experiments were predicted (Figure 1). Simulation results for the aerobic batch experiment, following 301 
WATS calibration with respirometric data, revealed a significant variation of XHw (5-fold increase followed by a 302 
53% decrease) over the course of the batch experiment, as expected by the initial substrate-to-microorganism 303 
ratio. This likely influences the kinetics of drug biomarker biotransformation, and shows the limited validity of 304 
the non-growth assumption typically considered in stability studies. XHw was predicted to reach a maximum 305 
concentration of 100 gCOD m
-3
 after 13 h, when SS became growth limiting. While XS1 was reduced via 306 
hydrolysis, XS2 remained almost constant during the experiment (due to extremely low hydrolysis rate kh2). 307 
Significant evaporation of MeOH (66% during BT-P1) was predicted, based on the results obtained in an 308 
additional set of evaporation experiments (SI Section S1.3). Under aerobic conditions, the calibrated WATS 309 
model well predicted OUR measurements from the respirometry tests as well as measured total and soluble COD 310 
during BT-P1 aerobic experiment (SI Figure S4 and Figure S7).  311 
WATS model predictions under anaerobic conditions (Figure 1) showed 61% decrease of XHw, with 312 
simultaneous growth of XSRB (2.8-fold increase) over the 2-d experiment. Concentration profiles for XS1 and XS2 313 
indicated comparably slow hydrolysis, with limited formation of SF. Almost complete fermentation of SF to SA 314 
within 30 h was predicted (Figure 1), with initial net formation and subsequent decrease of SA. The predicted 315 
non-limiting SF (during the first 30 h) and SA (over the entire experiment) were expected to support growth of 316 
XSRB. Notably, MeOH evaporation rate in anaerobic experiments was 2-fold lower than in the aerobic experiment 317 
(see also SI Figure S6), partly justifying the lower removal of total and soluble COD in the anaerobic 318 
experiment. Even though calibration of anaerobic WATS model was not performed and previously suggested 319 
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parameter values were used (SI Table S1), it was possible to predict SO4 variations under anaerobic conditions 320 
with reasonable approximation (SI Figure S7). Discrepancies between WATS simulations and total and soluble 321 
COD measured values could have resulted from, among others, underestimation of maximum specific growth 322 
rate for XSRB (μSRB=0.8 d
-1
, originally estimated for anaerobic biofilm
50
). Nevertheless, it should be noted that, 323 
available methods to determine WATS anaerobic model parameters are less structured and less conclusive
23,31
 324 
than for the aerobic model.
30
  325 
 326 
Sorption and transformation of drug biomarkers  327 
Solid-liquid partitioning  328 
Two wall-liquid partition coefficients, Kdw,1 (from AB-BT aerobic) and Kdw,2 (from AB-BT anaerobic) and two 329 
solid-liquid partition coefficients, Kd,1 (from SO1 and AB-SO1) and Kd,2 (from SO2 and AB-SO2) were 330 
estimated from respective experimental data (Figure 1 and SI Figure S9) using Eq. 1 and Eq. 2. Obtained Kdw 331 
and Kd values are presented in SI Figure S13 and Table S12. Based on the similarity of pH conditions (SI Figure 332 
S10), Kdw,1 and Kd,1 determinations were considered relevant to BT-P1 and BT-P2 aerobic experiments and Kdw,2  333 
and Kd,2 to BT-P1 and BT-P2 anaerobic experiments. Partitioning to reactor wall was found to be relevant (Kdw 334 
up to 0.16 L dm
-2 ▁	for THC) for all drug biomarkers except for MORG and 6MAM. Partitioning to suspended 335 
solids was found to be relevant for MPEH, METD, EDDP, BE, 6MAM, THCOH, and THCCOOH, with Kd 336 
values ranging from 0.11 L gTSS
-1
 (METD) to 0.80 L gTSS
-1
 (THCOH). Although THC is highly hydrophobic 337 
(logKow=7.61), we observed that all sorption of THC was related to partitioning to the reactor wall (poly(methyl 338 
methacrylate), Plexiglas). Notably, recorded pH data show a pH increase during experiments, crossing the pKa of 339 
some of the drug biomarkers. Variations of pH can potentially alter the speciation of the drug biomarker and 340 
possibly affect their sorption potential (see SI Section S5.2). 341 
 342 
Transformation of drug biomarkers: Pathways and kinetics 343 
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Measured and simulated (using combined WATS–ASM-X model) drug biomarker concentrations in batch 344 
experiments AB-BT, BT-P1 and BT-P2 are presented in Figure 1. All posterior distributions (densities) of 345 
estimated parameters are reported in SI Figure S22–23.  346 
The calibrated WATS⎼ASM-X model was then evaluated via forward simulations using the BT-P2 dataset. The 347 
effect of different redox conditions on transformation kinetics and the relative contribution of abiotic and biotic 348 
processes to the overall transformation of each drug biomarker (quantified by comparing the transformation rates 349 
kabio, d
-1
, and k
*
bioXSS, d
-1
) are summarized in Figure 2 (a–b and c–d, respectively).  The results obtained are 350 
presented separately for each group of drug biomarkers in the following paragraphs. In this study, 351 
biotransformation rate constants (kbio, L gCOD
-1
 d
-1
) for illicit drugs were estimated for the first time by 352 
accounting for microbial growth using the WATS–ASM-X framework. Thus, our results were compared with 353 
published literature in terms of TSS-normalized biotransformation rate constants (k
*
bioXSS, d
-1
) or relative 354 
conversion (%) during batch experiments (Figure 2c⎼d).  355 
 356 
Mephedrone. Under aerobic conditions, biotransformation (k
*
bio,ae,MEPHXSS =0.58 d
-1
) was found to dominate 357 
MEPH conversion over abiotic mechanisms (kabio,ae,MEPH=0.1 d
-1
), which is not the case under anaerobic 358 
conditions (k
*
bio,an,MEPHXSS =0 d
-1
; kabio,an,MEPH=0.18 d
-1
). Model predictions were in good agreement with 359 
measurements from the BT-P2 dataset (Figure 1). A few studies assessed the transformation of MEPH in 360 
wastewater; Ostman et al.
6
 reported 5% and 6% removal of MEPH in Milli-Q water and sewage, respectively, at 361 
room temperature over 24 h, being significantly less than what observed in the present study. MEPH is a 362 
relatively new psychoactive substance, and its consumption has been estimated by measuring MEPH itself as 363 
biomarker in wastewater influent.
51
  364 
Methadone. Net formation of EDDP (Figure 1) as a result of significant METD transformation (especially under 365 
aerobic conditions) was not observed and thus our data do not suggest EDDP as the major METD transformation 366 
product, as suggested for human metabolism.
12,37
 Moreover, N-demethylation of METD to EDDP was predicted 367 
to be unfeasible in wastewater.
39
 Hence, the transformation of EDDP and METD were considered as 368 
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independent processes (further discussion in SI Section S8). The abiotic METD transformation rate was higher 369 
under aerobic conditions (kabio,ae,METD=0.25 d
-1
; kabio,an.METD=0.15 d
-1
). Furthermore, aerobic biotransformation of 370 
METD was found to be significantly higher than for anaerobic conditions (kbio,ae,METD=1495 L gCOD
-1 
d
-1
; 371 
kbio,an,METD=0 L gCOD
-1 
d
-1
). Similarly, for EDDP, aerobic biotransformation was significantly higher than that 372 
obtained under anaerobic conditions (kbio,ae,EDDP=2.90 L gCOD
-1 
d
-1
, kbio,an,EDDP=0.81 L gCOD
-1 
d
-1
). The 373 
WATS⎼ASM-X model did not adequately predict BT-P2 experimental data for METD under aerobic conditions, 374 
whereas the model could be validated for other BT-P2 datasets. Former studies were inconclusive as to the 375 
removal of METD in wastewater, ranging from almost complete (wastewater in closed container at 4 °C after 3 376 
d)
52
 to low (<5%, in unfiltered wastewater at 19 °C, pH=7.4 after 1 d)
53
 or even negative removal (-8%, in 377 
wastewater at 20 °C and pH~7.5 after 12 h).
12
 Our results suggest that no formation of EDDP should be 378 
considered from METD, if EDDP is to be used as METD biomarker in WBE studies.   379 
Cocaine. The transformation pathway for COC drug biomarkers was defined according to Bisceglia et al.
14 
with 380 
negligible transformation of COC to EME as reported previously (see SI Figure S16).
3
 For all the experiments, 381 
the measured data (Figure 1) indicated net removal of COC, EME and CE and net formation of BE. For all COC 382 
biomarkers, abiotic processes dominated the overall transformation under aerobic conditions and especially 383 
under anaerobic conditions, at which (except for BE) no contribution of biotic processes was found. Slightly 384 
higher anaerobic kabio were found compared to aerobic rates (Figure 2a).  385 
For COC, EME and CE, simulation results obtained with the calibrated model agreed well with the measured 386 
independent dataset (BT-P2 aerobic and anaerobic), thereby validating the identified model structure. We note 387 
that the model for BE could be validated if only abiotic transformation was considered. The estimated 388 
transformation rates for COC, EME, and BE were in the range reported by Bisceglia et al.
36
 (untreated sewage at 389 
T=9 °C and T=23 °C and pH=7). In agreement with other study,
36
 our results indicate that hydrolysis is the 390 
governing transformation mechanism for COC and transformation products except for BE under anaerobic 391 
conditions (Figure 2d). Furthermore, since blank experiments were performed in mineral water, it may be 392 
concluded that hydrolysis is not solely bacterially-mediated, as reported previously.
36
 Estimated aerobic 393 
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biotransformation rate for COC (k
*
bio,ae,COCXSS=0.22 d
-1
) data was also comparable to estimated rates in 394 
unfiltered wastewater at 10 °C (0.1 d
-1
) and 20 °C (0.48 d
-1
) with  pH=7.5.
49
 However, transformation rates 395 
obtained in the present study for COC were lower than those reported by Plósz et al. (8.8 d
-1
) 
3
 for activated 396 
sludge (T=21 °C and pH=7.4), likely due to the presence of a biocenosis different from that prevailing in sewer 397 
systems. In WBE, BE is normally used as suitable biomarker for back-calculation of COC consumption. This 398 
study demonstrates that formation of BE from both COC and CE (when ethanol and cocaine coexist in blood) is 399 
significant (especially under aerobic conditions) and should be considered in back-calculation schemes.  400 
Heroin. HER transformation to 6MAM and then to MOR via two-step deacetylation has been reported.
54
 401 
However, rapid HER conversion (overall kbio,ae,HER=321.4 L gCOD
-1 
d
-1
, kbio,an,HER=824.1 L gCOD
-1 
d
-1
) did result 402 
in a significant 6MAM formation in BT-P1 experiments. Thus, an additional biotransformation product for HER 403 
was considered in the pathway. Furthermore, a mass balance analysis over MOR revealed that the fast decrease 404 
of MORG concentration (overall kbio,ae,MORG=1842.8 L gCOD
-1 
d
-1
, kbio,an,MORG=942.6 L gCOD
-1 
d
-1
) could be 405 
described if MORG was transformed not only to MOR
55
 but also to another (unknown) transformation product. 406 
This assumption was supported by the EAWAG transformation pathway model (SI Figure S27)
39
 and by 407 
experimental data reported by Senta et al.
49
 who also found an imbalance between formed MOR and removed 408 
MORG and 6MAM amounts. These two additional pathways were not considered for abiotic transformation of 409 
HER and MORG. As presented in Figure 1, MORG remained nearly unchanged in mineral water 410 
(kabio,ae,MORG=0.08 d
-1
, kabio,an,MORG=0 d
-1
) but was rapidly transformed in wastewater, possibly via extracellular β-411 
glucuronidase enzymes (abundant e.g. in fecal bacteria).
56,57
 Further details on the transformation pathways for 412 
HER and MORG are presented in SI Section S8. Although COE can potentially be metabolized to MOR in the 413 
human body,
37
 we considered MOR as a minor transformation product of COE in wastewater as previously 414 
reported.
38
  415 
Significant abiotic conversion was observed for 6MAM and MOR under both redox conditions, while abiotic 416 
transformation of COE was observed only under anaerobic conditions. Other identified transformations are 417 
dominantly microbially-mediated transformations (Figure 2c⎼d). HER removal of 40% and 80% (T=4 °C) after 418 
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1 day and 3 days in wastewater, respectively, has been previously reported.
52
 However, our results for HER are 419 
in closer agreement with data presented by Baker et al.
53
 i.e. 80% removal after 12 h (raw wastewater; T=19 °C, 420 
pH=7.4). In the same study, comparably high removal (85%) for MORG in both filtered and unfiltered 421 
wastewater and relatively low removal of 6MAM (12%) were also observed. Biotransformation rates for 6MAM 422 
and MORG under aerobic conditions (overall k
*
bio,ae,MORGXSS=32.2 d
-1
, k
*
bio,ae,6MAMXSS=0.63 d
-1
) were found to 423 
be significantly higher than the values reported in wastewater at pH=7.5 (0.94 d
-1
 for MORG, 0.12 d
-1
 for 6MAM 424 
at 10 °C; 2.4 d
-1
 for MORG and 0.19 d
-1
 for 6MAM at 20 °C).
49
 Previous studies on COE are inconclusive and 425 
estimated removal rates (1-d batch experiments) exhibit significant variation from no removal (sewage, room 426 
temperature)
6
 to comparably high (∼50% removal in 1:20-diluted activated sludge).58 Since 6MAM often occurs 427 
at non-detectable levels in samples taken from sewer systems, MOR has been proposed as the best biomarker to 428 
estimate heroin abuse levels.
59
 This approach necessitates the quantification of the therapeutic consumption of 429 
MOR that must be subtracted from the total MOR load measured in wastewater.
38,60
 In addition, evidence from 430 
this study shows the necessity of accounting for MOR formation from 6MAM and MORG. To our knowledge, 431 
this is the first study to evaluate transformation kinetics of six heroin biomarkers simultaneously.  432 
THC. With respect to the pathway identification (SI Figure S18), we initially hypothesized that THC 433 
transformation would be different from THC metabolic pathways in humans as transformation of THC to 434 
THCOH appears unfeasible in wastewater
39
 (SI Figure S27) while transformation of THCOH to THCCOOH 435 
may occur.
37,39
 This hypothesis was confirmed by our experimental results (Figure 1), which indicated no clear 436 
formation of THCOH, and independent in-sewer transformation for THC was thus considered. THC under 437 
aerobic conditions and THCOH and THCCOOH under anaerobic conditions (Figure 2c⎼d) underwent significant 438 
abiotic transformation (kabio,ae,THC=27.2 d
-1
, kabio,an,THCOH=1.9 d
-1
, kabio,an,THCCOOH=1.4 d
-1
). We note that the THC 439 
concentration could not be quantified during AB-BT and BT-P1 anaerobic experiments due to ILIS signal 440 
suppression.  441 
Removal rates reported in literature for THC biomarkers show significant variations. THCOH removal up to 442 
20% (unfiltered wastewater; T=20 °C, pH=7.5; duration: 3 days) has been reported
49
. Another investigation in 443 
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wastewater showed 40% THCOH removal (4 °C) after 3 days
52
, 40% THC removal and negligible THCCOOH 444 
removal (-20 °C) after 3 days.
61
 Castiglioni et al.
55
 have reported 8% removal of THCCOOH in wastewater (4 445 
°C) after 3 days. These results do not agree with our findings, which show significantly higher conversion rates 446 
for THC, THCOH and THCCOH (Figure 1). Furthermore, it is unclear to what extent the reported elimination 447 
was due to sorption—which in our study was found to be significant for THCOH and THCOOH (Kd,THCOH~0.7, 448 
Kd,THCOOH~0.8 L gTSS
-1
)—or to transformation.  449 
 450 
Factors influencing biomarker transformation 451 
Redox conditions. Aerobic and anaerobic conditions were found to have no major impact on abiotic 452 
transformation rates for most of the investigated substances, except for MORG, COE, and NCOE (Figure 2a). 453 
Conversely, differences between kbio values estimated under the two redox conditions were found to be 454 
significant for nearly all drug biomarkers (Figure 2b). Thus, redox conditions prevailing in sewer may 455 
significantly influence the microbially-mediated transformation of drug biomarkers. 456 
  457 
Transformation mechanisms. Abiotic transformation processes were found to be the dominating mechanism to 458 
the overall biomarker transformation (Figure 2c⎼d) for THC (aerobic conditions) MEPH, METD, COC, EME, 459 
CE, THCOH, and THCCOOH (anaerobic conditions). Conversely, insignificant abiotic contribution was 460 
observed for MEPH, METD, EDDP, HER, MORG, THCOH, and THCCOOH (aerobic conditions) and HER, 461 
MORG, and NCOE (anaerobic conditions). Overall, these results highlight the necessity of distinguishing 462 
between abiotic and microbially-mediated transformation (e.g. through control experiments in the absence of 463 
active biomass) when assessing the fate of illicit drugs in sewer systems.    464 
Model complexity. The uncertainty imposed by neglecting biomass growth processes and propagating to the 465 
estimated parameter values was additionally assessed (Figure 3). Values of kbio (L gCOD
-1
 d
-1
) were estimated 466 
with the BT-P1 dataset using two model complexity levels, i.e. ASM-X with no biomass growth and the 467 
combined WATS⎼ASM-X implementation. The comparison revealed that neglecting active biomass 468 
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concentration dynamics during a batch experiment can result in up to 385% (4.85:1) overestimation of kbio under 469 
aerobic conditions, whereas no major difference was observed under anaerobic conditions. For drug biomarkers 470 
with comparably high kbio (e.g. METD, MORG, THCCOOH), estimated parameter values were less sensitive to 471 
the dynamics of active biomass concentrations than for those chemicals with kbio≤20 L gCOD
-1 
d
-1
 (Figure 3a-1 472 
and a-2). This can be explained by the fact that, at high biotransformation rate constants, complete removal of 473 
drug biomarker would be achieved before biomass undergoes significant growth. Our results suggest that the 474 
increased model complexity of the combined WATS⎼ASM-X model can be justified by the avoided parameter 475 
uncertainties introduced by the prediction of the microbial growth processes under aerobic conditions. This was 476 
not the case under anaerobic conditions (Figure 3b), and reliable parameter estimation was possible by 477 
calibrating a simplified modeling framework with ASM-X only. These conclusions were drawn on the optimal 478 
kinetic model complexity and can also be considered true for sewer catchment simulation models used to back-479 
calculate drug abuse rates in urban areas. 480 
In this study, we have presented an assessment of the removal of illicit drug biomarkers in wastewater, 481 
comprising the partitioning onto solid medium (i.e. suspended solids and reactor wall), abiotic transformation 482 
and microbiologically mediated transformations. Results obtained demonstrate that redox conditions can have a 483 
significant impact on transformation kinetics. Modeling the transformation of drug biomarkers in raw 484 
wastewater required consideration of the significant growth of biomass under aerobic conditions and thus 485 
describing the dynamics of different COD fractions. Our results suggest that the estimation of transformation 486 
rates and rate constants are significantly influenced by transformation pathways, as drug biomarkers present in 487 
the medium can often be formed from other biomarkers. These findings underscore the importance of accounting 488 
for in-sewer transformation of drug biomarkers, and may lead to more accurate estimations of drug consumption.  489 
in-sewer transformation of drug biomarkers, and may lead to more accurate estimations of drug consumption. 490 
While this study focused on fate of selected drug biomarkers in presence of suspended biomass, ongoing 491 
research activity focuses on transformation and sorption of drug biomarkers in sewer biofilms. Along with in-492 
sewer transformation, a more comprehensive assessment of all sources of uncertainty is required for the 493 
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selection of suitable biomarker candidate for back-calculation purposes. Further research activity is also required 494 
to consider in-sewer transport processes, and thus calculate residence time distribution, at a catchment or sub-495 
catchment level. Wastewater-based epidemiological engineering is an emerging field, in which mathematical 496 
models, such as the WATS⎼ASM-X developed in this study, can play a key role as decision support tools for 497 
epidemiological studies. 498 
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Table 1. Primary and secondary metabolic processes under aerobic and anaerobic conditions considered in the WATS–ASM-X framework.  
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WATS aerobic: µH: maximum specific growth rate of XHw; YHw: heterotrophic growth yield; KSw: affinity constant of XHw for SS; qm: maintenance rate; kh1: rapid hydrolysis rate; kh2: slow hydrolysis rate; KX1: 
affinity constant for rapid hydrolysis; KX2: affinity constant for slow hydrolysis; αw: aerobic Arrhenius temperature coefficient; keva,ae: aerobic methanol evaporation rate; T: Temperature  
WATS anaerobic: µSRB: maximum specific growth rate of XSRB; YSRB: growth yield of XSRB; KSRB,S: affinity constant of XSRB for SS; KSRB,SO4: affinity constant of XSRB for SSO4; dH: decay rate of XHw; ηh: 
anaerobic reduction factor for hydrolysis; qfe: maximum fermentation rate; Kfe: affinity constant for SF; αS: anaerobic Arrhenius temperature coefficient; keva,an: anaerobic methanol evaporation rate 
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abiotic transformation rate; kabio,CJ: abiotic formation rate; kbio,LI: biotransformation rate constant; kbio,CJ: biotic formation rate constant; fSS: TSS-to-particulate-COD ratio; M: biomarker molecular weight 
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Figure 1. Experimental data and simulation results for primary and secondary metabolic processes under aerobic and 
anaerobic conditions. Primary metabolic processes: aerobic WATS model outputs including heterotrophic biomass 
XHw, soluble substrate SS and rapid, XS1, and slow, XS2, hydrolysable fractions. Anaerobic WATS model outputs, 
including XHw, sulfate reducing bacteria, XSRB, fermentation product (VFA), SF, fermentable substrate, SA, XS1, and XS2. 
Evaporation of methanol, SMe, is also simulated for both redox conditions. Secondary metabolic processes: data  
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related to AB-BT aerobic, AB-BT anaerobic, BT-P1 aerobic, BT-P1 anaerobic, BT-P2 aerobic, and BT-P2 anaerobic 
experiments. While WATS⎼ASM-X is calibrated with AB and BT-P1 data, BT-P2 data is used to validate the 
WATS⎼ASM-X model. Markers are measured data and lines are simulation results. The shaded area reflects 95% 
credibility interval of model prediction.  
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Figure 2. Comparing the effect of aerobic and anaerobic conditions on abiotic transformation (a) and 
biotransformation rates (b) as well as comparing abiotic transformation with biotransformation under aerobic (c) and 
anaerobic (d) conditions. Undetermined transformations are indicated with asterisk (*). Abbreviations: T.P. = 
transformation product(s). (a) and (b):	kbio (L gCOD
-1
 d
-1
) is the biotransformation rate constant using WATS⎼ASM-X.	
Error bar is the upper bound of the 95% credibility interval of estimated parameters. (c) and (d): estimated 
transformation rates (kabio and k
*
bioXSS) are used as indicators of the contribution of transformation processes—abiotic 
(filled blue) against biotic (shaded brown)—to the overall transformations (kabio +k
*
bioXSS). k
*
bio (L gTSS
-1
 d
-1
) is the 
TSS-normalized biotransformation rate estimated using ASM-X model without WATS.  
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Figure 3. Comparing estimated kbio using WATS⎼ASM-X considering biomass changes (X axis) with kbio estimated 
using ASM-X with a fixed biomass fraction (Y axis) under aerobic conditions (a-1 and a-2) and under anaerobic 
conditions (b). Dashed lines indicate the ratio of estimated parameters.  
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